(Total Views: 380)
Posted On: 04/01/2020 4:21:45 PM
Post# of 72444
It's really too late for this go-round but hopefully it spurs substantial government investment in the future for antibiotics and antivirals. Even if we get something approved and on the production lines in a month or two...the toll will be high.
A paltry $1B of Barda money could have had a dozen of these nightmare scenario drugs tested and ready to go on the shelves, Brilacidin included. This is a case where the capital markets failed to incentivize the development of these kinds of drugs.
Now we'll spend trillions in stimulus trying to buoy and recover from this decimation when a couple billion dollars of research and production could have significantly blunted the impact of this virus.
This is a failure across multiple US administrations and the world. It will be a costly lesson both in dollars and lives. Hopefully we can rebound quickly and take the lesson to heart.
A paltry $1B of Barda money could have had a dozen of these nightmare scenario drugs tested and ready to go on the shelves, Brilacidin included. This is a case where the capital markets failed to incentivize the development of these kinds of drugs.
Now we'll spend trillions in stimulus trying to buoy and recover from this decimation when a couple billion dollars of research and production could have significantly blunted the impact of this virus.
This is a failure across multiple US administrations and the world. It will be a costly lesson both in dollars and lives. Hopefully we can rebound quickly and take the lesson to heart.
(2)
(1)
